LifeStance Health Group, Inc.

LFST Nasdaq SEC CIK 1845257
Follow LifeStance Health Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $455.9M +25.3% vs same quarter last year
Net income $22.4M +1978.5% vs same quarter last year
EPS, diluted -
Operating cash flow $37M +35.7% vs same quarter last year
Revenue by quarter
$325.5M
$333M
$345.3M
$363.8M
$382.2M
$403.5M
$435.4M
$455.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.4B$9.7M
FY24$1.3B−$57.4M
FY23$1.1B−$186.3M
FY22$859.5M−$215.6M
FY21$1.4M−$307.2M
FY20--
FY19$212.5M$5.7M
FY18--
MarginsShare of revenue
  • Operating margin
  • Net margin
−30000%−20000%−10000%0%10000%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY251.7%0.7%
FY24−2.5%−4.6%
FY23−17.9%−17.6%
FY22−24.5%−25.1%
FY21−19816.8%−21259.3%
FY20--
FY197.2%2.7%
FY18--
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50M$100M$150MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$110M
FY24$85.7M
FY23−$57.4M
FY22−$26.5M
FY21−$85.1M
FY20-
FY19$2.7M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • LifeStance Health
  • Healthcare median
−30000%−20000%−10000%0%10000%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearLifeStance HealthHealthcare median
FY250.7%−30.6%
FY24−4.6%−47%
FY23−17.6%−58%
FY22−25.1%−80.4%
FY21−21259.3%−71.9%
FY20-−62.2%
FY192.7%−46.3%
FY18-−49.6%